526 related articles for article (PubMed ID: 16426869)
21. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
[TBL] [Abstract][Full Text] [Related]
22. Termination of absence status epilepticus by low-dose intravenous levetiracetam.
Altenmüller DM; Kühn A; Surges R; Schulze-Bonhage A
Epilepsia; 2008 Jul; 49(7):1289-90. PubMed ID: 18638286
[No Abstract] [Full Text] [Related]
23. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
Misra UK; Kalita J
Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
[TBL] [Abstract][Full Text] [Related]
24. Intravenous levetiracetam for epileptic seizure emergencies in older people.
Beyenburg S; Reuber M; Maraite N
Gerontology; 2009; 55(1):27-31. PubMed ID: 18953167
[TBL] [Abstract][Full Text] [Related]
25. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
[TBL] [Abstract][Full Text] [Related]
26. The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus.
Wheless JW; Treiman DM
Epilepsia; 2008 Dec; 49 Suppl 9():74-8. PubMed ID: 19087120
[TBL] [Abstract][Full Text] [Related]
27. Role of intravenous levetiracetam in acute seizure management of children.
Kirmani BF; Crisp ED; Kayani S; Rajab H
Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
[TBL] [Abstract][Full Text] [Related]
28. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
İşgüder R; Güzel O; Ceylan G; Yılmaz Ü; Ağın H
J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam as a treatment option in non-convulsive status epilepticus.
Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
31. IV levetiracetam in the management of non-convulsive status epilepticus.
Farooq MU; Naravetla B; Majid A; Gupta R; Pysh JJ; Kassab MY
Neurocrit Care; 2007; 7(1):36-9. PubMed ID: 17657655
[TBL] [Abstract][Full Text] [Related]
32. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes.
Rossetti AO; Bromfield EB
Eur Neurol; 2005; 54(1):34-8. PubMed ID: 16103676
[TBL] [Abstract][Full Text] [Related]
33. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
Knake S; Gruener J; Hattemer K; Klein KM; Bauer S; Oertel WH; Hamer HM; Rosenow F
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):588-9. PubMed ID: 17898030
[TBL] [Abstract][Full Text] [Related]
34. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
[TBL] [Abstract][Full Text] [Related]
35. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus.
Möddel G; Bunten S; Dobis C; Kovac S; Dogan M; Fischera M; Dziewas R; Schäbitz WR; Evers S; Happe S
J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):689-92. PubMed ID: 19448097
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.
Aiguabella M; Falip M; Villanueva V; de la Peña P; Molins A; Garcia-Morales I; Saiz RA; Pardo J; Tortosa D; Sansa G; Miró J
Seizure; 2011 Jan; 20(1):60-4. PubMed ID: 21145758
[TBL] [Abstract][Full Text] [Related]
37. Management of refractory status epilepticus at a tertiary care centre in a developing country.
Tripathi M; Vibha D; Choudhary N; Prasad K; Srivastava MV; Bhatia R; Chandra SP
Seizure; 2010 Mar; 19(2):109-11. PubMed ID: 20034814
[TBL] [Abstract][Full Text] [Related]
38. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
Navarro V; Dagron C; Elie C; Lamhaut L; Demeret S; Urien S; An K; Bolgert F; Tréluyer JM; Baulac M; Carli P;
Lancet Neurol; 2016 Jan; 15(1):47-55. PubMed ID: 26627366
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
Cagnotti G; Odore R; Gardini G; Amedeo S; Bertone I; Guerriero G; Lentini L; Dappiano E; D'Angelo A
BMC Vet Res; 2018 Jun; 14(1):189. PubMed ID: 29914474
[TBL] [Abstract][Full Text] [Related]
40. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
Steinhoff BJ; Trinka E; Wieser HG;
Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
